Abstract Lipid metabolic changes under diseased conditions, particularly in solid tumors, are attracting increased attention. However, in non-solid tumors, including most hematopoietic tumors, lipid analyses are scarce. Multiple myeloma (MM) is a plasma cell disorder arising from bone marrow, and the lipid status of MM cells has not been reported yet. In this study, we analyzed flow cytometry-sorted single MM cells and normal plasma cells (NPCs) using matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS), a twodimensional label-free mass spectrometry technique for biomolecular analysis, to obtain specific lipid information. We isolated 1.31-5.77 % of MM cells and 0.03-0.24 % of NPCs using fluorescence-activated cell sorting (FACS). Analysis of purified cells using MALDI-IMS at the single-cell level revealed that the peak intensity and ion signals of phosphatidylcholine [PC (16:0/20:4)+H] + at m/z 782.5 were significantly decreased in MM cells compared to NPCs. By examining particular cell populations rather than cell mixtures, our method can become a suitable tool for the analysis of rare cell populations at the single-cell level and advance the understanding of MM progression.
Introduction
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Electronic supplementary material The online version of this article (doi:10.1007/s00216-015-8741-z) contains supplementary material, which is available to authorized users. spectrometry (MALDI-IMS), and cancer progression, particularly in solid tumors [1] [2] [3] , or other abnormalities [4] , has been getting increased attention in recent years. MALDI-IMS is a label-free two-dimensional mass spectrometry (MS) technique that has been applied to visualize the spatial distribution of molecules in biological samples [5, 6] . Phosphatidylcholines (PC) are the most abundant phospholipid species in mammalian cells, accounting for more than 30 % of total lipids [7] . The altered metabolic status of PC in tumor tissue, as revealed by MALDI-IMS, shows potential for identifying new biomarkers and therapeutic targets [1, 3] . However, hematopoietic malignancies such as leukemia and multiple myeloma, which do not form solid tumor masses but remain suspended in circulation,
have not yet been analyzed by MALDI-IMS.
Multiple myeloma (MM) is a malignant disorder of antibody-producing plasma cells, arising from bone marrow and accounting for 1.5 % of all malignancies [8] and 10 % of hematopoietic malignancies [9] . Studies on clonal evolution [10] , intercellular signaling pathways [11] , interaction with bone marrow stromal cells [12] , and antibody therapy [13] are contributing to increasingly improved overall survival. Recently, lipid metabolism studies such as on the use of inhibitors of fatty acid synthesis and their effects on MM cell survival have been reported [14] , whereas the cellular lipid profile of MM cells is still unknown.
Here, we aimed to analyze flow cytometry-sorted MM cells and corresponding normal plasma cells (NPCs) using MALD I-IMS at the single-cell level. Data obtained by MALDI scanning were complemented with subsequent analysis of the lipid status of MM compared to their normal counterpart (NPC) at the single-cell level.
Materials and methods

Subjects, samples, and cells
All experiments in this study were specifically approved by the Ethics Committee of Hamamatsu University School of Medicine. Three MM patients and three healthy volunteers were enrolled, of whom informed consent was obtained in written form before starting operations. Bone marrow aspirates were collected in vacuum blood collection tubes supplemented with heparin in RPMI-1640 medium (Nissui Pharmaceutical, Tokyo, Japan) containing 10 % fetal bovine serum (FBS; JRH Biosciences, Lenexa, KS, USA). The U266 human MM-derived cell line was obtained from the American Type Culture Collection (Rockville, MD, USA) and cultured in RPMI-1640 medium containing 10 % FBS, 2 mM L-glutamine (Nissui Pharmaceutical), 100 μg/ml streptomycin (Meiji Seika Pharma, Tokyo, Japan), and 200 U/ml penicillin (Meiji Seika Pharma) at 37°C in a humidified atmosphere of 5 % CO 2 .
Flow cytometry
Primary MM cells were isolated from the bone marrow aspirates of three patients (MM1, MM2, and MM3), and NPCs were isolated from the bone marrow aspirates of three healthy volunteers (NPC1, NPC2, and NPC3) by fluorescenceactivated cell sorting (FACS). Bone marrow samples (1.5 ml) in RPMI 1640 medium were incubated in up to 50 ml of hemolytic buffer (150 mM ammonium chloride, 10 mM potassium hydrogen carbonate, and 450 μl 0.2 M EDTA in a total of 1000 ml) for 15 min and centrifuged at 240×g for 5 min. Cells were collected in a 15-ml falcon tube, washed with 10 ml of MACS buffer (Miltenyi Biotec, Bergisch Gladbach, Germany), and centrifuged again at 240×g for 5 min. U266 cells were washed in the same way.
Bone marrow samples were incubated with each of the following monoclonal antibodies in the dark at 4°C for 10 min: anti-CD38 Alexa Fluor™ 488 (clone HIT2; BioLegend, San Diego, CA, USA), anti-CD138 peridinin chlorophyll A protein (PerCP)-cyanin 5.5 (Cy5.5) (clone DL-101; BioLegend), anti-CD45 allophycocyanin (APC) (clone 5B1; Miltenyi Biotec), anti-CD19 phycoerythrin (PE) (clone HIB19; BioLegend), and anti-CD56 PE-cyanin 7 (Cy7) (clone MEM188; BioLegend). After incubation, samples were rinsed with MACS buffer to remove unbound antibody, filtered through a 50-μm Patrec CellTrics® filter (Partec GmbH, Görlitz, Germany), and flash centrifuged before sorting. [15, 16] . Isolated cells were stained with May-Grünwald-Giemsa cytochemical staining solution (Sigma-Aldrich, St. Louis, MO, USA); each plasma cell was confirmed morphologically as previously described [17] .
ITO slide preparation
Poly-L-lysine (Sigma-Aldrich) was applied onto the surface of an indium tin oxide (ITO)-coated glass slide (Bruker Daltonics, Bremen, Germany) to provide a positively charged monolayer [18] that reduces cell loss during sample preparation and assists in the cells' adherence to the glass surface [19] . A 12-well flexiPERM ® plate (Sarstedt, Tokyo, Japan) was affixed to the slide; MM cells and NPCs were applied into each well at a density of 1 × 10 4 cells/well, and cytocentrifuged using CytoSpin™ 4 (Thermo Scientific, Waltham, MA, USA) to spin the cells onto the surface of the glass slide. Cells were fixed with 100 μl of 0.25 % glutaraldehyde for 15 min and rinsed three times with 150 mM ammonium acetate buffer (pH 7.5) [20] . Samples were dried using an air blower and stored at −80°C until use. U266 cells (3×10 4 ), stained with anti-CD38-Alexa Fluor TM 488 antibody, were fixed onto the same glass slides to verify the accuracy of sample preparation and analysis conditions.
MALDI-IMS
A thin layer of 2,5-dihydroxyacetophenone (DHAP; Tokyo Chemical Industry, Tokyo, Japan) was applied as a matrix onto the surface of cells on ITO-coated glass slides, using a vapor deposition device (RK27-4069; Shimadzu, Kyoto, Japan) as previously described [21] . To visualize the sample, a fluorescence microscope with a lens range of ×1.5 to ×40 was used. All experiments were performed using an atmospheric pressure MALDI high-resolution ionization source attached to a quadrupole ion trap-time-of-flight mass separator (iMScope; Shimadzu, Kyoto, Japan). An Nd:YAG (355 nm) laser with a repetition capacity of ∼1 kHz was equipped as irradiation source. Mass resolution was set to R=10,000 (fullwidth half-height maximum at m/z 1000). Laser intensity was set at 30 % to obtain an optimal signal-to-noise ratio. Two hundred laser pulses were summed for each mass spectrum. The ablation area caused by the laser was 5 μm in diameter. Positive ions from a sample area of 25×25 μm centering a cell were obtained in a mass range of m/z 700 to 900. To establish the optimum analysis condition before the clinical sample analysis, a 75×75 μm area of U266 cells was analyzed. The mass spectra were calibrated externally using a standard peptide calibration mixture containing 5 pmol/μl of insulin B fragment (amino acid residue [22] [23] [24] [25] , m/z 2093.1). As samples were obtained, prepared, and analyzed at different times, we put U266 cells along with each sample in different wells to verify the sample preparation and accuracy of analysis (Electronic Supplementary Material, Fig. S1 ). Selected ion images were generated by Imaging MS Solution (Shimadzu) with a mass filter width of 0.05 Da for subsequent statistical analyses. The assigned peak's identification was done using MALDI-MS/ MS analysis. The laser intensity was 35 %, and 43 eV collision energy was applied in the mass range of m/z 100 to 800 at positive ion mode in a pixel area of 19,600 (pitch 10×10 μm).
A quantitative validation was examined with a dried droplet cell analysis. The extracts were prepared using 1.0×10 6 cells/ml of chloroform extract using one slide of MM cells and NPCs. Standard solutions (2.5-40 μg/ml) of PC (16:0/ 20:4) (Avanti Polar Lipids, Alabaster, AL, USA) were prepared by dissolving chloroform and serial dilution. After preparing each solution, 0.5 μl of these solutions was spotted on ITO-coated glass slides precoated with DHAP [21, 22] and the slide spotted with each extract were used for MALDI-IMS analysis by iMScope.
Data analysis
Using Imaging MS Solution software, 16 cells of each sample were merged and total ion current normalization was done to generate the spectra. The top 50 high-intensity peaks (judged by the area under the curve) were picked up from the mass spectra of the MM1 sample data. The Human Metabolome Database (HMDB) [23, 24] , an electronic database containing detailed information on human small metabolites, was used to identify phospholipids from the list of m/z values corresponding to the peaks. The m/z values identified as phospholipids were taken into consideration for the NPC1 sample to compare the phospholipid ion intensities between MM1 and 
NPC1
. Phospholipid m/z values of intensity differences between MM1 and NPC1 of at least 1.6 times as a threshold were short-listed. Short-listed phospholipid intensities were submitted to statistical analysis.
Statistical analysis
For statistical analysis, R (The R Foundation for Statistical Computing) and EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), an R commander designed for clinical statistics, were used [25] . Statistical significance between groups of MM cells and NPCs with respect to their intensities was determined by one-way analysis of variance (ANOVA) followed by the Tukey multiple comparison test, considering p<0.05 as significantly different.
Results
Establishment of optimal analysis conditions for MALD I-IMS
Prior to clinical sample analysis, MALDI experiments with U266 cells were performed to establish optimal analysis conditions for suspended scattered cells (Fig. 1) . The major spectra at m/z 808.5, 734.5, 760.5, 752.5, 836.5, and 728.5 of phospholipid molecules derived from an area of attached cells show remarkable high intensity, and no mass spectra at the same m/z values were obtained from cell-free background areas (Fig. 1a) . Figure 1b shows the ion images by MALDI-IMS analysis and the fluorescence images of CD38-positive U266 cells visualized by a fluorescence microscope equipped with iMScope. Ion abundance of phospholipid molecules was colocalized in cell areas, while no ion signals of phospholipid molecules were detected in cell-free background areas (Fig. 1b) . Therefore, we established optimal analysis conditions for single-cell MALDI-IMS analysis.
Isolation of MM cells and NPCs
We isolated MM cells and NPCs from bone marrow aspirates of patients and healthy volunteers, respectively. Using FACS, 1.31-5.77 % of MM cells and 0.03-0.24 % of NPCs were collected from total bone marrow nucleated cells (Fig. 2a) . Sorted cells stained with May-Grünwald-Giemsa showed plasma cell morphology such as well-defined perinuclear zones containing the Golgi apparatus, and an eccentrically Fig. 2 placed round nucleus containing dense masses of chromatin (Fig. 2b ).
Single-cell MALDI-IMS analysis with MM cells and NPCs
Based on the results of the experiments with U266 cells, isolated MM cells and NPCs were examined by single-cell MALDI-IMS. We chose five phospholipid molecules which revealed over 1.6 times ion intensity differences between MM1 and NPC1 (Table 1 ) and carried out further statistical analysis. The mean intensities of the ion at m/z 782.5 were significantly lower (p<0.001) in MM cells than in NPCs (Fig. 3) . The remaining short-listed candidates did not show consistent differences between all samples of MM cells and NPCs (Electronic Supplementary Material Fig. S2 ). Dried droplet cell analysis using one set of MM cells and NPCs for quantitative validation was also carried out. The concentration of the molecule corresponding to m/z 782.5 in NPC was 11.7 μg/ml whereas the amount in MM cells was 3.02 μg/ml. The assigned peak at m/z 782.5 was identified as [PC (16: (Fig. 4) . According to the HMDB database (http://www.hmdb.ca) and previous reports [26] , the PC molecule represented by m/z 782. were found in the cell attachment sites of each NPC (Fig. 5a ). On the other hand, the signals in each MM cell were lower than that in NPCs (Fig. 5a ). The average of mass spectra of PC (16:0/20:4) also showed lower intensity in MM cells than in NPCs (Fig. 5b) . According to these results, we revealed PC (16:0/20:4) was significantly decreased in MM cells than in NPCs by single-cell MALDI-IMS analysis.
Discussion
In this study, we succeeded for the first time to obtain the lipid status in MM cells compared with their normal counterpart NPCs using MALDI-IMS in the single-cell level. Schober et al. was the first to develop single-cell MALDI-IMS analysis using the HeLa cell line [27] ; however, no report has examined comparative lipid profiling by single-cell MALDI-IMS analysis. Several reports have been published on comparative analysis of single cells using secondary ion mass spectrometry (SIMS), and these reports have demonstrated fatty acid profiles in the single-cell level using clinical samples such as breast cancer stem cell and MM cell [28, 29] . Liquid chromatography-MS was also used for analyzing the profile of lipids in a purified cell; however, this method requires extraction and bulk amounts of cells and misses specific information on rare target populations due to the heterogeneity of cells in tissues or groups [28, 30] . Another advantage of MALDI-IMS is that it is unnecessary to label any markers. Therefore, single-cell MALDI-IMS analysis is a useful method for demonstrating lipid profiles and detecting rare target populations in human clinical samples. We suppose that the following methodological advances in the field of IMS made it possible to analyze such small objects: (1) the combined use of a microscope together with IMS and an improved laser ablation area to increase the spatial resolution up to 5 μm [27, 31] ; (2) the use of DHAP as a matrix for improved sensitivity of phospholipid detection by MALDI-IMS [21] ; and (3) the sample preparation strategies such as the introduction of glutaraldehyde for cell fixation in IMS analysis [20] .
Our study revealed that PC (16:0/20:4) significantly decreased in MM cells compared with NPCs (Figs. 3, 4 , and 5). In our knowledge, no study indicating a direct relationship between this PC (16:0/20:4) and cancer has been reported whereas Guo et al. has demonstrated that some polyunsaturated fatty acids (PUFA) and PCs containing PUFA such as C 20:4 and PC(38:4) were significantly decreased in the cancer microenvironment compared with the adjacent normal tissue of six cancer types (breast, lung, colorectal, esophageal, gastric, and thyroid) [32] . We have also reported that C 16:0 was decreased in MM cells than in NPCs by TOF-SIMS analysis [29] . Therefore, the decreased level of PC (16: [33] [34] [35] . Recent studies have reported that C 16:0 revealed significant degradation by conversion to a longer-chain fatty acid in breast cancer and hepatocellular carcinoma, and this degradation was caused by the high expression of Elovl6 [36, 37] . We have also revealed that C 16:0 and C 16:1 were significantly decreased in MM cells than that in NPCs [29] , and this assumption is supported by upregulated Elovl6 mRNA in MM cells found in the cancer microarray database BOncomine^ [38] . Inhibitors of lipid metabolic enzymes are attracting attention as new therapeutic agents [39] [40] [41] . Our new approach of changing lipid contents of MM cells is considered to contribute to the development of therapeutic agents associated with cancer lipid metabolism. In addition, lipid profile data of MM cells will help in the selection of patients for lipid-related treatments.
Following the success of single-cell MALDI-IMS analysis of MM cells, studies on other hematological malignancies and difficult-to-obtain cell populations are assumed to start soon. Beside hematological tumor cells, circulating solid tumor cells and cancer stem cells can be suitable subjects of examination. Single-cell lipid analysis and elucidation of lipid profiles of cell populations are considered to contribute to the advancement of knowledge on the biology and lipid metabolism of cells and promote the understanding of developmental mechanisms of disease.
Conclusions
In summary, we performed single-cell MALDI-IMS analysis on objects tens of micrometers in size such as MM cells and NPCs. We generated lipid profiles of MM cells and revealed lipid changes in MM cells compared to NPCs. The abundance of PC (16:0/20:4) was significantly decreased in MM cells. Our study is considered to contribute to further research and the development of new therapeutic agents related to lipid metabolism in MM cells.
